Zoledronate Infusion Funding
Auckland | Waitematā | Counties Manukau
Service Information
Update: From 1 July 2026 this funding has been extended across the Auckland Region as a fully funded service.
Included:
Funding of the administration of Zoledronate infusion for patients who fulfill specified criteria.
Zoledronate can be administered within the referring GP's clinic, or at a registered Infusion Centre, upon referral (see form here).
See POAC claiming schedule for funding rates. No patient co-payment should be charged.
Criteria
Confirm patient meets POAC funding criteria below.
Funding criteria:
Patient resident in Auckland Region or enrolled with an Auckland Region GP, AND
Patients eGFR >35, AND
Patient holds a CSC card
AND
Recommended by hospital specialist, including previous administration as an inpatient or outpatient, OR
Serious adverse reaction to Alendronate, OR
Unsuitable for use of oral medication
For recommended frequency of dosing, see the Medications for Osteoporosis HealthPathway